Novel Dihydroisoquinolinone-Amide Compounds as GIPR Agonists for Treating Type 2 Diabetes Mellitus and Obesity
Year: 2026
Type: editorial
Abstract: High Resolution Image Download MS PowerPoint Slide Provided herein are novel dihydroisoquinolinone-amide compounds as GIPR agonists, pharmaceutical compositions, use of such compounds in treating type 2 diabetes mellitus and obesity, and processes for preparing such compounds.
Source: ACS Medicinal Chemistry Letters
Author: Ram W. Sabnis
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7154580835